• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

一种用于鼻电位差参数的多读者评分系统。

A multiple reader scoring system for Nasal Potential Difference parameters.

机构信息

Department of Medicine, The Gregory Fleming James Cystic Fibrosis Research Center, University of Alabama at Birmingham, Birmingham, AL, USA.

Department of Medicine, The Gregory Fleming James Cystic Fibrosis Research Center, University of Alabama at Birmingham, Birmingham, AL, USA.

出版信息

J Cyst Fibros. 2017 Sep;16(5):573-578. doi: 10.1016/j.jcf.2017.04.011. Epub 2017 Apr 29.

DOI:10.1016/j.jcf.2017.04.011
PMID:28465124
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5671639/
Abstract

BACKGROUND

Nasal Potential Difference (NPD) is a biomarker of CFTR activity used to diagnose CF and monitor experimental therapies. Limited studies have been performed to assess agreement between expert readers of NPD interpretation using a scoring algorithm.

METHODS

We developed a standardized scoring algorithm for "interpretability" and "confidence" for PD (potential difference) measures, and sought to determine the degree of agreement on NPD parameters between trained readers.

RESULTS

There was excellent agreement for interpretability between NPD readers for CF and fair agreement for normal tracings but slight agreement of interpretability in indeterminate tracings. Amongst interpretable tracings, excellent correlation of mean scores for Ringer's Baseline PD, Δ, and Δ was observed. There was slight agreement regarding confidence of the interpretable PD tracings, resulting in divergence of the Ringers and Δ, and ΔCl PDs between "high" and "low" confidence CF tracings.

CONCLUSION

A multi-reader process with adjudication is important for scoring NPDs for diagnosis and in monitoring of CF clinical trials.

摘要

背景

鼻内压差(NPD)是一种 CFTR 活性的生物标志物,用于诊断 CF 并监测实验性治疗。目前已经进行了一些有限的研究,以评估使用评分算法的 NPD 解读专家读者之间的一致性。

方法

我们开发了一种用于 PD(潜在差异)测量的“可解释性”和“置信度”的标准化评分算法,并试图确定训练有素的读者在 NPD 参数上的一致性程度。

结果

CF 患者的 NPD 读者在可解释性方面具有极好的一致性,而在正常描记方面具有良好的一致性,但在不确定描记方面具有轻微的一致性。在可解释的描记中,观察到 Ringer's Baseline PD、Δ 和 Δ 的平均评分具有极好的相关性。可解释 PD 描记的置信度有轻微的一致性,导致“高”和“低”置信 CF 描记之间的 Ringers 和 Δ 以及 ΔCl PD 之间存在分歧。

结论

对于 CF 的诊断和 CF 临床试验的监测,使用评分算法进行 NPD 的多读者处理和裁决非常重要。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/76f6/5671639/966a0384d562/nihms914430f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/76f6/5671639/fa2039e072ad/nihms914430f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/76f6/5671639/966a0384d562/nihms914430f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/76f6/5671639/fa2039e072ad/nihms914430f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/76f6/5671639/966a0384d562/nihms914430f2.jpg

相似文献

1
A multiple reader scoring system for Nasal Potential Difference parameters.一种用于鼻电位差参数的多读者评分系统。
J Cyst Fibros. 2017 Sep;16(5):573-578. doi: 10.1016/j.jcf.2017.04.011. Epub 2017 Apr 29.
2
Transepithelial nasal potential difference (NPD) measurements in cystic fibrosis (CF).囊性纤维化(CF)患者的经上皮鼻腔电位差(NPD)测量
Med Wieku Rozwoj. 2013 Jan-Mar;17(1):13-7.
3
Insights into the variability of nasal potential difference, a biomarker of CFTR activity.鼻腔电位差变化的洞察,CFTR 活性的生物标志物。
J Cyst Fibros. 2020 Jul;19(4):620-626. doi: 10.1016/j.jcf.2019.09.015. Epub 2019 Nov 4.
4
Does integration of various ion channel measurements improve diagnostic performance in cystic fibrosis?各种离子通道测量的整合是否能提高囊性纤维化的诊断性能?
Ann Am Thorac Soc. 2014 May;11(4):562-70. doi: 10.1513/AnnalsATS.201311-412OC.
5
Nasal potential difference measurements in diagnosis of cystic fibrosis: an international survey.鼻腔电势差测量在囊性纤维化诊断中的应用:一项国际调查。
J Cyst Fibros. 2014 Jan;13(1):24-8. doi: 10.1016/j.jcf.2013.08.006. Epub 2013 Sep 7.
6
The CF-CIRC study: a French collaborative study to assess the accuracy of cystic fibrosis diagnosis in neonatal screening.CF-CIRC研究:一项法国合作研究,旨在评估新生儿筛查中囊性纤维化诊断的准确性。
BMC Pediatr. 2006 Oct 3;6:25. doi: 10.1186/1471-2431-6-25.
7
Basic protocol for transepithelial nasal potential difference measurements.经上皮鼻腔电位差测量的基本方案。
J Cyst Fibros. 2004 Aug;3 Suppl 2:151-5. doi: 10.1016/j.jcf.2004.05.032.
8
Measurement of nasal potential difference in young children with an equivocal sweat test following newborn screening for cystic fibrosis.对新生儿筛查后可疑汗试验的婴幼儿进行鼻电位差测量。
Thorax. 2010 Jun;65(6):539-44. doi: 10.1136/thx.2009.123422.
9
Nasal potential difference outcomes support diagnostic decisions in cystic fibrosis.鼻电位差结果有助于支持囊性纤维化的诊断决策。
J Cyst Fibros. 2016 Sep;15(5):579-82. doi: 10.1016/j.jcf.2016.06.009. Epub 2016 Jul 15.
10
Nasal potential difference in congenital bilateral absence of the vas deferens.先天性双侧输精管缺如患者的鼻电位差
Am J Respir Crit Care Med. 1998 Sep;158(3):896-901. doi: 10.1164/ajrccm.158.3.9711029.

引用本文的文献

1
The measurement properties of tests and tools used in cystic fibrosis studies: a systematic review.用于囊性纤维化研究的测试和工具的测量特性:系统评价。
Eur Respir Rev. 2021 May 11;30(160). doi: 10.1183/16000617.0354-2020. Print 2021 Jun 30.
2
Research advances in molecular mechanisms underlying the pathogenesis of cystic fibrosis: From technical improvement to clinical applications (Review).囊性纤维化发病机制分子机制的研究进展:从技术改进到临床应用(综述)。
Mol Med Rep. 2020 Dec;22(6):4992-5002. doi: 10.3892/mmr.2020.11607. Epub 2020 Oct 16.
3
Standardized Measurement of Nasal Membrane Transepithelial Potential Difference (NPD).

本文引用的文献

1
A Phase I/IIa Safety and Efficacy Study of Nebulized Liposome-mediated Gene Therapy for Cystic Fibrosis Supports a Multidose Trial.雾化脂质体介导的基因治疗囊性纤维化的I/IIa期安全性和有效性研究支持多剂量试验。
Am J Respir Crit Care Med. 2015 Dec 1;192(11):1389-92. doi: 10.1164/rccm.201506-1193LE.
2
Repeated nebulisation of non-viral CFTR gene therapy in patients with cystic fibrosis: a randomised, double-blind, placebo-controlled, phase 2b trial.反复雾化非病毒 CFTR 基因治疗囊性纤维化患者:一项随机、双盲、安慰剂对照、2b 期试验。
Lancet Respir Med. 2015 Sep;3(9):684-691. doi: 10.1016/S2213-2600(15)00245-3. Epub 2015 Jul 3.
3
鼻黏膜跨上皮电位差(NPD)的标准化测量
J Vis Exp. 2018 Sep 13(139):57006. doi: 10.3791/57006.
Nasal potential difference measurements in diagnosis of cystic fibrosis: an international survey.
鼻腔电势差测量在囊性纤维化诊断中的应用:一项国际调查。
J Cyst Fibros. 2014 Jan;13(1):24-8. doi: 10.1016/j.jcf.2013.08.006. Epub 2013 Sep 7.
4
Optimizing nasal potential difference analysis for CFTR modulator development: assessment of ivacaftor in CF subjects with the G551D-CFTR mutation.优化 CFTR 调节剂开发的鼻电位差分析:评估 G551D-CFTR 突变 CF 受试者中的 ivacaftor。
PLoS One. 2013 Jul 26;8(7):e66955. doi: 10.1371/journal.pone.0066955. Print 2013.
5
Reduced sodium transport with nasal administration of the prostasin inhibitor camostat in subjects with cystic fibrosis.经鼻给予前脯素抑制剂卡莫司他可减少囊性纤维化患者的钠转运。
Chest. 2013 Jul;144(1):200-207. doi: 10.1378/chest.12-2431.
6
Results of a phase IIa study of VX-809, an investigational CFTR corrector compound, in subjects with cystic fibrosis homozygous for the F508del-CFTR mutation.一项研究 VX-809(一种研究用的 CFTR 校正化合物)的 IIa 期临床研究结果,该化合物用于 F508del-CFTR 突变纯合子的囊性纤维化患者。
Thorax. 2012 Jan;67(1):12-8. doi: 10.1136/thoraxjnl-2011-200393. Epub 2011 Aug 8.
7
Nasal potential difference measurements to assess CFTR ion channel activity.用于评估囊性纤维化跨膜传导调节因子(CFTR)离子通道活性的鼻电位差测量
Methods Mol Biol. 2011;741:69-86. doi: 10.1007/978-1-61779-117-8_6.
8
Chronic ataluren (PTC124) treatment of nonsense mutation cystic fibrosis.慢性氨苯砜(PTC124)治疗无义突变型囊性纤维化。
Eur Respir J. 2011 Jul;38(1):59-69. doi: 10.1183/09031936.00120910. Epub 2011 Jan 13.
9
Effect of VX-770 in persons with cystic fibrosis and the G551D-CFTR mutation.VX-770 治疗囊性纤维化患者与 G551D-CFTR 突变。
N Engl J Med. 2010 Nov 18;363(21):1991-2003. doi: 10.1056/NEJMoa0909825.
10
An international randomized multicenter comparison of nasal potential difference techniques.国际多中心随机对照研究比较鼻电位差技术。
Chest. 2010 Oct;138(4):919-28. doi: 10.1378/chest.10-0179. Epub 2010 May 14.